topamax
PreclinicalSmall molecule
Tevatopamax is one of 24 small molecule programs targeting Headache. It is currently in Preclinical.
2
Indications
10
Total Trials
0
Active Trials
23
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
24 competitors in Cocaine Dependence
#DrugCompanyPhaseTrials
1Keppra
UCBApproved
Epidiolex
Jazz PharmaceuticalsApproved
Namenda
AbbVieApproved
Seroquel
EEngelhard Arzneimittel GmbH & Co.KG
Approved
Prometrium
FerringApproved
Dilantin
VViatris Specialty LLC
Approved
Mifeprex
DDanco
Approved
Normodyne
AAlvogen Korea
Approved
Nimotop
AAzurity Pharmaceuticals
Approved
Acetadote
AArbor Pharmaceuticals, Inc.
Approved
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Fasting Conditions3 trials
Interaction1 trial
3 more indications
Total Joint Arthroplasty1 trial
Headache1 trial
Peripheral Nerve Block and Topiramate in the Treatment of Medication Overuse Headaches
Completed·—·N/A·NCT03767062·90 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for topamax. EMBL-EBI & Wellcome Sanger Institute.
- [4]